Uterine sarcomas - Recent progress and future challenges

European Journal of Radiology

Volumn 78, Issue 1, 2011, Pages 30-40

  Seddon, Beatrice M ^a   Davda, Reena ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Endometrial stromal sarcoma; Undifferentiated endometrial sarcoma; Uterine leiomyosarcoma

Indexed keywords

AMONAFIDE; AROMATASE INHIBITOR; BEVACIZUMAB; CISPLATIN; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; GEMCITABINE; GESTAGEN; GONADORELIN AGONIST; IFOSFAMIDE; MITOMYCIN C; MITOXANTRONE; PACLITAXEL; PROGESTERONE RECEPTOR; SUNITINIB; TOPOTECAN; TRABECTEDIN; TRIMETREXATE;

ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; AFRICAN AMERICAN; AGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURGERY; DOPPLER FLOWMETRY; ENDOMETRIUM SARCOMA; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMATOSIS; LEIOMYOSARCOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MITOSIS INDEX; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY METASTASIS; OVERALL SURVIVAL; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; SALPINGOOOPHORECTOMY; SCORING SYSTEM; TUMOR VOLUME; UTERUS SARCOMA; UTERUS TUMOR; VAGINA BLEEDING;

CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SARCOMA; UTERINE NEOPLASMS;

EID: 79954706262     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.12.057     Document Type: Article

References (167)

1. Cancer incidence - UK statistics [Internet Communication].
2. S.M. Ueda, D.S. Kapp, and M.K. Cheung Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths Am J Obstet Gynecol 198 2 2008 218 226
3. F. Amant, A. Coosemans, M. biec-Rychter, D. Timmerman, and I. Vergote Clinical management of uterine sarcomas Lancet Oncol 10 12 2009 1188 1198
4. E. D'Angelo, and J. Prat Uterine sarcomas: a review Gynecol Oncol 116 1 2010 131 139
5. A. Gadducci, S. Cosio, A. Romanini, and A.R. Genazzani The management of patients with uterine sarcoma: a debated clinical challenge Crit Rev Oncol Hematol 65 2 2008 129 142
6. J.F. Lin, and B.M. Slomovitz Uterine sarcoma 2008 Curr Oncol Rep 10 6 2008 512 518
7. J.H. Nam, and J.Y. Park Update on treatment of uterine sarcoma Curr Opin Obstet Gynecol 22 1 2010 36 42
8. R. O'Cearbhaill, and M.L. Hensley Optimal management of uterine leiomyosarcoma Expert Rev Anticancer Ther 10 2 2010 153 169
9. N.S. Reed The management of uterine sarcomas Clin Oncol (R Coll Radiol) 20 6 2008 470 478
10. S. Sleijfer, C. Seynaeve, and J. Verweij Gynaecological sarcomas Curr Opin Oncol 19 5 2007 492 496 (Pubitemid 47356608)
11. F. Zagouri, A.M. Dimopoulos, S. Fotiou, V. Kouloulias, and C.A. Papadimitriou Treatment of early uterine sarcomas: disentangling adjuvant modalities World J Surg Oncol 7 2009 38
12. F. Zagouri, H. Linardou, A.M. Dimopoulos, and C.A. Papadimitriou Management of advanced stage uterine sarcomas: a bone of contention Eur J Gynaecol Oncol 30 5 2009 483 492
13. F.A. Tavassoli, and P. Devilee Tumours of the breast and female genital organs 2003 International Agency for Research on Cancer
14. R.L. Kempson, and M.R. Hendrickson Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus Mod Pathol 13 3 2000 328 342 (Pubitemid 30207516)
15. I. Gorai, T. Yanagibashi, and A. Taki Uterine carcinosarcoma is derived from a single stem cell: an in vitro study Int J Cancer 72 5 1997 821 827 (Pubitemid 27431526)
16. H. Wada, T. Enomoto, and M. Fujita Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors Cancer Res 57 23 1997 5379 5385 (Pubitemid 27516377)
17. W.G. McCluggage Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J Clin Pathol 55 5 2002 321 325 (Pubitemid 34494168)
18. H.J. Norris, and H.B. Taylor Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors Cancer 19 6 1966 755 766
19. K.L. Chang, G.S. Crabtree, S.K. Lim-Tan, R.L. Kempson, and M.R. Hendrickson Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases Am J Surg Pathol 14 5 1990 415 438 (Pubitemid 20140662)
20. H.L. Evans Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma Cancer 50 10 1982 2170 2182 (Pubitemid 13203626)
21. M.M. Leitao, R.A. Soslow, and D. Nonaka Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Cancer 101 6 2004 1455 1462 (Pubitemid 39180402)
22. M.R. Raspollini, G. Amunni, and A. Villanucci Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome J Chemother 15 6 2003 596 602 (Pubitemid 38241410)
23. K. Bodner, B. Bodner-Adler, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters Anticancer Res 23 1B 2003 729 732 (Pubitemid 36358480)
24. Y.J. Ioffe, A.J. Li, and C.S. Walsh Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles Gynecol Oncol 115 3 2009 466 471
25. J.I. Koontz, A.L. Soreng, and M. Nucci Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors Proc Natl Acad Sci U S A 98 11 2001 6348 6353 (Pubitemid 32488241)
26. M.R. Nucci, D. Harburger, J. Koontz, C.P. Dal, and J. Sklar Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms Am J Surg Pathol 31 1 2007 65 70 (Pubitemid 46036903)
27. S. Kurihara, Y. Oda, and Y. Ohishi Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases Am J Surg Pathol 32 8 2008 1228 1238
28. F. Micci, I. Panagopoulos, B. Bjerkehagen, and S. Heim Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma Cancer Res 66 1 2006 107 112 (Pubitemid 43166015)
29. J. Yang, X. Du, and K. Chen Genetic aberrations in soft tissue leiomyosarcoma Cancer Lett 275 1 2009 1 8
30. S. Sagae, K. Yamashita, and S. Ishioka Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan Oncology 67 1 2004 33 39 (Pubitemid 39370348)
31. S. Leibsohn, G. d'Ablaing, D.R. Mishell Jr., and J.B. Schlaerth Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas Am J Obstet Gynecol 162 4 1990 968 974
32. J. Goldberg, I. Burd, F.V. Price, and R. Worthington-Kirsch Leiomyosarcoma in a premenopausal patient after uterine artery embolization Am J Obstet Gynecol 191 5 2004 1733 1735 (Pubitemid 39491210)
33. K. Iihara, K. Hirano, Y. Fujioka, and A. Sakamoto Leiomyosarcoma with dedifferentiation in a premenopausal patient discovered after uterine artery embolization Pathol Int 57 10 2007 681 687 (Pubitemid 47353044)
34. H. Hricak, D. Tscholakoff, and L. Heinrichs Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms Radiology 158 2 1986 385 391 (Pubitemid 16160600)
35. Y. Yamashita, M. Torashima, and M. Takahashi Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications Radiology 189 3 1993 721 725 (Pubitemid 23354484)
36. S.E. Rha, J.Y. Byun, and S.E. Jung CT and MRI of uterine sarcomas and their mimickers AJR Am J Roentgenol 181 5 2003 1369 1374 (Pubitemid 37296418)
37. K. Hata, T. Hata, R. Maruyama, and M. Hirai Uterine sarcoma: can it be differentiated from uterine leiomyoma with Doppler ultrasonography? A preliminary report Ultrasound Obstet Gynecol 9 2 1997 101 104 (Pubitemid 27163222)
38. R. Aviram, Y. Ochshorn, and O. Markovitch Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings J Clin Ultrasound 33 1 2005 10 13 (Pubitemid 40019167)
39. I. Szabo, A. Szantho, L. Csabay, Z. Csapo, K. Szirmai, and Z. Papp Color Doppler ultrasonography in the differentiation of uterine sarcomas from uterine leiomyomas Eur J Gynaecol Oncol 23 1 2002 29 34 (Pubitemid 34178096)
40. A. Sahdev, S.A. Sohaib, I. Jacobs, J.H. Shepherd, D.H. Oram, and R.H. Reznek MR imaging of uterine sarcomas AJR Am J Roentgenol 177 6 2001 1307 1311 (Pubitemid 33081470)
41. A. Kido, K. Togashi, T. Koyama, T. Yamaoka, T. Fujiwara, and S. Fujii Diffusely enlarged uterus: evaluation with MR imaging Radiographics 23 6 2003 1423 1439 (Pubitemid 37487519)
42. L.B. Schwartz, M. Zawin, M.L. Carcangiu, R. Lange, and S. McCarthy Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril 70 3 1998 580 587 (Pubitemid 28435653)
43. Y.O. Tanaka, M. Nishida, H. Tsunoda, Y. Okamoto, and H. Yoshikawa Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings J Magn Reson Imaging 20 6 2004 998 1007 (Pubitemid 39577902)
44. A. Goto, S. Takeuchi, K. Sugimura, and T. Maruo Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus Int J Gynecol Cancer 12 4 2002 354 361 (Pubitemid 34839833)
45. D. Cornfeld, G. Israel, M. Martel, J. Weinreb, P. Schwartz, and S. McCarthy MRI appearance of mesenchymal tumors of the uterus Eur J Radiol 74 2 2009 241 249
46. S. Fujii, E. Matsusue, and J. Kigawa Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results Eur Radiol 18 2 2008 384 389 (Pubitemid 351234060)
47. K. Tamai, T. Koyama, and T. Saga The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas Eur Radiol 18 4 2008 723 730 (Pubitemid 351447778)
48. T. Namimoto, Y. Yamashita, and K. Awai Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas Eur Radiol 19 11 2009 2756 2764
49. M. Shida, M. Murakami, and H. Tsukada F-18 fluorodeoxyglucose uptake in leiomyomatous uterus Int J Gynecol Cancer 17 1 2007 285 290 (Pubitemid 46214006)
50. T. Tsujikawa, Y. Yoshida, and T. Mori Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET - initial experience Radiology 248 2 2008 599 605
51. N. Umesaki, T. Tanaka, and M. Miyama Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-d-glucose in the diagnosis of uterine leiomyosarcoma: a case report Clin Imaging 25 3 2001 203 205 (Pubitemid 33001567)
52. N. Umesaki, T. Tanaka, and M. Miyama Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging Gynecol Oncol 80 3 2001 372 377 (Pubitemid 32207538)
53. C.P. Raut, M.R. Nucci, and Q. Wang Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma Eur J Cancer 45 16 2009 2818 2824
54. O. Zivanovic, M.M. Leitao, and A. Iasonos Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on cancer staging systems J Clin Oncol 27 12 2009 2066 2072
55. P. Pautier, C. Genestie, and A. Rey Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 88 6 2000 1425 1431 (Pubitemid 30155181)
56. F.J. Major, J.A. Blessing, and S.G. Silverberg Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 4 Suppl. 1993 1702 1709 (Pubitemid 23056094)
57. D.S. Kapp, J.Y. Shin, and J.K. Chan Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 4 2008 820 830 (Pubitemid 351240576)
58. R.L. Giuntoli, D.S. Metzinger, and C.S. DiMarco Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy Gynecol Oncol 89 3 2003 460 469 (Pubitemid 36687793)
59. K. Bodner, B. Bodner-Adler, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study J Reprod Med 48 2 2003 95 100 (Pubitemid 36249753)
60. R. Blom, H. Malmstrom, and C. Guerrieri Endometrial stromal sarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 17 cases Int J Gynecol Cancer 9 2 1999 98 104 (Pubitemid 29220745)
61. K. Bodner, B. Bodner-Adler, and A. Obermair Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients Gynecol Oncol 81 2 2001 160 165 (Pubitemid 32424154)
62. J.K. Chan, N.M. Kawar, and J.Y. Shin Endometrial stromal sarcoma: a population-based analysis Br J Cancer 99 8 2008 1210 1215
63. A. Gadducci, E. Sartori, and F. Landoni Endometrial stromal sarcoma: analysis of treatment failures and survival Gynecol Oncol 63 2 1996 247 253 (Pubitemid 26398607)
64. A. Haberal, F. Kayikcioglu, N. Boran, E. Caliskan, N. Ozgul, and M.F. Kose Endometrial stromal sarcoma of the uterus: analysis of 25 patients Eur J Obstet Gynecol Reprod Biol 109 2 2003 209 213 (Pubitemid 36809134)
65. B. Larson, C. Silfversward, B. Nilsson, and F. Pettersson Endometrial stromal sarcoma of the uterus. A clinical and histopathological study. The Radiumhemmet series 1936-1981 Eur J Obstet Gynecol Reprod Biol 35 2-3 1990 239 249 (Pubitemid 20184068)
66. R.R. Nordal, G.B. Kristensen, J. Kaern, A.E. Stenwig, E.O. Pettersen, and C.G. Trope The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma Gynecol Oncol 62 2 1996 254 259 (Pubitemid 26274808)
67. J. Prat FIGO staging for uterine sarcomas Int J Gynaecol Obstet 104 3 2009 177 178
68. O.M. Salazar, T.A. Bonfiglio, and S.F. Patten Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy Cancer 42 3 1978 1161 1170 (Pubitemid 9054574)
69. J.Y. Park, D.Y. Kim, and D.S. Suh Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007 J Cancer Res Clin Oncol 134 12 2008 1277 1287
70. M.M. Leitao, Y. Sonoda, M.F. Brennan, R.R. Barakat, and D.S. Chi Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus Gynecol Oncol 91 1 2003 209 212 (Pubitemid 37188613)
71. J.P. Shah, C.S. Bryant, S. Kumar, R. li-Fehmi, J.M. Malone Jr., and R.T. Morris Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma Obstet Gynecol 112 5 2008 1102 1108
72. B. Barney, J.D. Tward, T. Skidmore, and D.K. Gaffney Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma? Int J Gynecol Cancer 19 7 2009 1232 1238
73. A. Berchuck, S.C. Rubin, W.J. Hoskins, P.E. Saigo, V.K. Pierce, and J.L. Lewis Jr. Treatment of endometrial stromal tumors Gynecol Oncol 36 1 1990 60 65 (Pubitemid 20038003)
74. M.C. Chu, G. Mor, C. Lim, W. Zheng, V. Parkash, and P.E. Schwartz Low-grade endometrial stromal sarcoma: hormonal aspects Gynecol Oncol 90 1 2003 170 176 (Pubitemid 37338093)
75. W.Y. Kim, J.W. Lee, and C.H. Choi Low-grade endometrial stromal sarcoma: a single center's experience with 22 cases Int J Gynecol Cancer 18 5 2008 1084 1089
76. A.J. Li, R.L. Giuntoli, and R. Drake Ovarian preservation in stage I low-grade endometrial stromal sarcomas Obstet Gynecol 106 6 2005 1304 1308 (Pubitemid 41668950)
77. N.S. Reed, C. Mangioni, and H. Malmstrom Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874) Eur J Cancer 44 6 2008 808 818
78. A. Kong, I. Simera, M. Collingwood, C. Williams, and H. Kitchener Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis Ann Oncol 18 10 2007 1595 1604 (Pubitemid 47506245)
79. S.E. Brooks, M. Zhan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 93 1 2004 204 208 (Pubitemid 38429571)
80. S. Sampath, T.E. Schultheiss, J.K. Ryu, and J.Y. Wong The role of adjuvant radiation in uterine sarcomas Int J Radiat Oncol Biol Phys 76 3 2010 728 734
81. C.A. Leath III, W.K. Huh, and J. Hyde Jr. A multi-institutional review of outcomes of endometrial stromal sarcoma Gynecol Oncol 105 3 2007 630 634 (Pubitemid 46734182)
82. H.D. Weitmann, T.H. Knocke, H. Kucera, and R. Potter Radiation therapy in the treatment of endometrial stromal sarcoma Int J Radiat Oncol Biol Phys 49 3 2001 739 748 (Pubitemid 32112199)
83. A. Gadducci, F. Landoni, and E. Sartori Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 1 1996 25 32 (Pubitemid 26234541)
84. G.A. Omura, J.A. Blessing, and F. Major A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study J Clin Oncol 3 9 1985 1240 1245 (Pubitemid 15226529)
85. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration Lancet 350 9092 1997 1647 1654
86. P.J. Woll, M. van Glabbeke, and P. Hohenberger Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): interim analysis of a randomised phase III trial 2007 ASCO annual meeting proceedings part I J Clin Oncol 25 18S 2007 10008 [Abstract]
87. M.L. Hensley, R. Maki, and E. Venkatraman Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial J Clin Oncol 20 12 2002 2824 2831 (Pubitemid 34651511)
88. M.L. Hensley, J.A. Blessing, R. Mannel, and P.G. Rose Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial Gynecol Oncol 109 3 2008 329 334 (Pubitemid 351754961)
89. M.L. Hensley, J.A. Blessing, K. Degeest, O. Abulafia, P.G. Rose, and H.D. Homesley Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study Gynecol Oncol 109 3 2008 323 328
90. M.L. Hensley, N. Ishill, and R. Soslow Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study Gynecol Oncol 112 3 2009 563 567
91. J.Y. Blay, and C.A. Le Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven Oncologist 14 10 2009 1013 1020
92. S. Sleijfer, C. Seynaeve, and J. Verweij Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care Oncologist 10 10 2005 833 841 (Pubitemid 43152701)
93. A.I. Spira, and D.S. Ettinger The use of chemotherapy in soft-tissue sarcomas Oncologist 7 4 2002 348 359 (Pubitemid 34919959)
94. G.A. Omura, F.J. Major, and J.A. Blessing A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas Cancer 52 4 1983 626 632 (Pubitemid 13025913)
95. G.P. Sutton, F.B. Stehman, H. Michael, P.C. Young, and C.E. Ehrlich Estrogen and progesterone receptors in uterine sarcomas Obstet Gynecol 68 5 1986 709 714 (Pubitemid 16005591)
96. K.Y. Look, A. Sandler, J.A. Blessing, J.A. Lucci III, and P.G. Rose Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) study Gynecol Oncol 92 2 2004 644 647 (Pubitemid 38183157)
97. H.B. Muss, B.N. Bundy, L. Adcock, and J. Beecham Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group Am J Clin Oncol 13 1 1990 32 34 (Pubitemid 20114555)
98. J.T. Thigpen, J.A. Blessing, J. Beecham, H. Homesley, and E. Yordan Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study J Clin Oncol 9 11 1991 1962 1966
99. T. Thigpen, J.A. Blessing, E. Yordan, F. Valea, and L. Vaccarello Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study Gynecol Oncol 63 1 1996 120 122 (Pubitemid 26337977)
100. R. Asbury, J.A. Blessing, R. Buller, J.H. Malfetano, J. Walker, and B.U. Sevin Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study Am J Clin Oncol 21 2 1998 145 146 (Pubitemid 28193157)
101. D.S. Miller, J.A. Blessing, L.C. Kilgore, R. Mannel, and L.L. Van Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group study Am J Clin Oncol 23 4 2000 355 357 (Pubitemid 32429146)
102. H.O. Smith, J.A. Blessing, and L. Vaccarello Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group Gynecol Oncol 84 1 2002 140 144 (Pubitemid 34056480)
103. D.G. Gallup, J.A. Blessing, W. Andersen, and M.A. Morgan Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a Gynecologic Oncology Group study Gynecol Oncol 89 1 2003 48 51 (Pubitemid 36403646)
104. M. Van Glabekke, J. Verweij, I. Judson, and O.S. Nielsen Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas Eur J Cancer 38 4 2002 543 549 (Pubitemid 34185394)
105. G. Sutton, J.A. Blessing, and J.H. Malfetano Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study Gynecol Oncol 62 2 1996 226 229 (Pubitemid 26274804)
106. J.H. Edmonson, J.A. Blessing, J.A. Cosin, D.S. Miller, D.E. Cohn, and J. Rotmensch Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study Gynecol Oncol 85 3 2002 507 510 (Pubitemid 34651893)
107. S. Leyvraz, M. Zweifel, and G. Jundt Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas Ann Oncol 17 4 2006 646 651
108. EORTC protocol 62012: randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma 2010 [Internet Communication]
109. J.O. Bay, I. Ray-Coquard, and J. Fayette Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis Int J Cancer 119 3 2006 706 711 (Pubitemid 43955727)
110. R.G. Maki, J.K. Wathen, and S.R. Patel Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected] J Clin Oncol 25 19 2007 2755 2763 (Pubitemid 47123184)
111. B. Seddon, M. Scurr, and R.L. Jones Phase II study of gemcitabine and docetaxel as first-line chemotherapy in locally advanced/metastatic leiomyosarcoma J Clin Oncol 27 2009 15s [Suppl.; Abstract 10528]
112. R. Garcia-Carbonero, J.G. Supko, and R.G. Maki Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study J Clin Oncol 23 24 2005 5484 5492
113. C.A. Le, J.Y. Blay, and I. Judson Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial J Clin Oncol 23 3 2005 576 584 (Pubitemid 46224235)
114. R. Garcia-Carbonero, J.G. Supko, and J. Manola Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy J Clin Oncol 22 8 2004 1480 1490 (Pubitemid 41103631)
115. A. Yovine, M. Riofrio, and J.Y. Blay Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients J Clin Oncol 22 5 2004 890 899 (Pubitemid 41103601)
116. G.D. Demetri, S.P. Chawla, and M.M. von Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules J Clin Oncol 27 25 2009 4188 4196
117. F. Grosso, R. Sanfilippo, and R.L. Jones Role of trabectedin (T) in the management of advanced uterine leiomyosarcoma (U-LM) J Clin Oncol 27 2009 15s [Suppl.; Abstract 10530]
118. F. Amant, K.A. De, and C.B. Van Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma Br J Cancer 97 9 2007 1194 1199 (Pubitemid 350035798)
119. L. Katz, M.J. Merino, H. Sakamoto, and P.E. Schwartz Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors Gynecol Oncol 26 1 1987 87 97 (Pubitemid 17213019)
120. D.R. Scribner Jr., and J.L. Walker Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace Gynecol Oncol 71 3 1998 458 460 (Pubitemid 29022338)
121. K.Y. Terada, J. Davis, J. Kitayama, and D. Shimizu Hormonal treatment of metastatic endometrial stromal sarcoma J Clin Oncol 27 2009 [Suppl.; Abstract e16576]
122. F.C. Maluf, P. Sabbatini, L. Schwartz, J. Xia, and C. Aghajanian Endometrial stromal sarcoma: objective response to letrozole Gynecol Oncol 82 2 2001 384 388 (Pubitemid 32730624)
123. J.P. Spano, J.C. Soria, and M. Kambouchner Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma Med Oncol 20 1 2003 87 93 (Pubitemid 36344030)
124. C. Burke, and K. Hickey Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue Obstet Gynecol 104 5 Pt 2 2004 1182 1184
125. C.A. Lo, S.C. Huang, C.L. Ho, C.C. Tzeng, C.Y. Chou, and K.F. Hsu Discordant responses to progestin in a patient with uterine low-grade smooth-muscle tumors metastatic to the lung J Obstet Gynaecol Res 31 5 2005 394 398
126. T. Uchida, K. Nakakawaji, and J. Sakamoto The effectiveness of medroxyprogesterone in the treatment of multiple metastasizing leiomyosarcomas: report of a case Surg Today 26 2 1996 138 141 (Pubitemid 26088328)
127. R. Koivisto-Korander, A. Leminen, and O. Heikinheimo Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma Obstet Gynecol 109 2 Pt2 2007 512 514 (Pubitemid 46146844)
128. M.P. Hardman, J.J. Roman, A.F. Burnett, and A.D. Santin Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor Obstet Gynecol 110 2 Pt 2 2007 518 520 (Pubitemid 47417749)
129. R. O'Cearbhaill, Q. Zhou, and A. Iasonos Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors Gynecol Oncol 116 3 2010 424 429
130. J. Verweij, P.G. Casali, and J. Zalcberg Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial Lancet 364 9440 2004 1127 1134 (Pubitemid 39296599)
131. J. Folkman Angiogenesis and its inhibitors Important Adv Oncol 1985 42 62
132. B. Escudier, T. Eisen, and W.M. Stadler Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 2 2007 125 134 (Pubitemid 46089673)
133. R.J. Motzer, T.E. Hutson, and P. Tomczak Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 2 2007 115 124 (Pubitemid 46089672)
134. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 23 2004 2335 2342 (Pubitemid 38702844)
135. A. Sandler, R. Gray, and M.C. Perry Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 24 2006 2542 2550 (Pubitemid 44917502)
136. D.S. McMeekin, M.W. Sill, and K.M. Darcy A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study Gynecol Oncol 106 3 2007 596 603 (Pubitemid 47304476)
137. D.R. D'Adamo, S.E. Anderson, and K. Albritton Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas J Clin Oncol 23 28 2005 7135 7142
138. Gemcitabine hydrochloride and docetaxel with or without bevacizumab in treating patients with advanced or recurrent uterine leiomyosarcoma 2010 [Internet Communication]
139. L.Q. Chow, and S.G. Eckhardt Sunitinib: from rational design to clinical efficacy J Clin Oncol 25 7 2007 884 896 (Pubitemid 350002890)
140. G.D. Demetri, A.T. van Oosterom, and C.R. Garrett Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial Lancet 368 9544 2006 1329 1338 (Pubitemid 44528723)
141. M.L. Hensley, M.W. Sill, and D.R. Scribner Jr. Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study Gynecol Oncol 115 3 2009 460 465
142. R.G. Maki, D.R. D'Adamo, and M.L. Keohan Phase II study of sorafenib in patients with metastatic or recurrent sarcomas J Clin Oncol 27 19 2009 3133 3140
143. K. Scotlandi, and P. Picci Targeting insulin-like growth factor 1 receptor in sarcomas Curr Opin Oncol 20 4 2008 419 427
144. S.R. Patel, A. Pappo, and J. Crowley Phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recurrent or refractory sarcomas J Clin Oncol 27 2009 15s [Suppl.; Abstract 10503]
145. X. Wan, and L.J. Helman The biology behind mTOR inhibition in sarcoma Oncologist 12 8 2007 1007 1018 (Pubitemid 47359144)
146. S.P. Chawla, A.W. Tolcher, and A. Staddon Updated results of a phase II trial of AP23573, a novel mTOR inhibitor, in patients (pts) with advanced soft tissue or bone sarcomas ASCO annual meeting proceedings part I J Clin Oncol 24 June (18S (Suppl.)) 2006 9505 [Abstract]
147. U. Pastorino, M. Valente, and M. Gasparini Lung resection for metastatic sarcomas: total survival from primary treatment J Surg Oncol 40 4 1989 275 280 (Pubitemid 19112006)
148. S.H. Blackmon, N. Shah, and J.A. Roth Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival Ann Thorac Surg 88 3 2009 877 884
149. D. Gossot, C. Radu, and P. Girard Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg 87 1 2009 238 243
150. S. Jordan, P. Goldstraw, and E. Belcher Prognostic factors for long term survival after pulmonary metastatectomy in sarcoma patients: a 16 year experience Connective Tissue Oncology Society annual meeting 2008 [Abstract]
151. J. Pfannschmidt, J. Klode, T. Muley, H. Dienemann, and H. Hoffmann
152. A. Rehders, S.B. Hosch, P. Scheunemann, N.H. Stoecklein, W.T. Knoefel, and M. Peiper Benefit of surgical treatment of lung metastasis in soft tissue sarcoma Arch Surg 142 1 2007 70 75 (Pubitemid 46106049)
153. R. Smith, Y. Pak, W. Kraybill, and J.M. Kane III Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy Eur J Surg Oncol 35 4 2009 356 361
154. K. Steinke, P.E. Sewell, and D. Dupuy Pulmonary radiofrequency ablation - an international study survey Anticancer Res 24 1 2004 339 343 (Pubitemid 38279729)
155. C.J. Simon, D.E. Dupuy, and T.A. DiPetrillo Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients Radiology 243 1 2007 268 275 (Pubitemid 46579719)
156. R. Lencioni, L. Crocetti, and R. Cioni Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol 9 7 2008 621 628
157. S. Strauss, A.R. Gillams, and B. Seddon Radiofrequency ablation of pulmonary metastases is safe and feasible in patients with relapsed bone and soft tissue sarcoma Connective Tissue Oncology Society annual meeting 2008 [Abstract]
158. S.S. Lo, A.J. Fakiris, and B.S. Teh Stereotactic body radiation therapy for oligometastases Expert Rev Anticancer Ther 9 5 2009 621 635
159. CyberKnife® Robotic Radiosurgery System Product Fact Sheet 2010 [Internet Communication]
160. E. Lartigau, X. Mirabel, B. Prevost, T. Lacornerie, F. Dubus, and T. Sarrazin Extracranial stereotactic radiotherapy: preliminary results with the CyberKnife Onkologie 32 4 2009 209 215
161. U.N. Rao, S.D. Finkelstein, and M.W. Jones Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas Mod Pathol 12 11 1999 1001 1009
162. Y.L. Zhai, Y. Kobayashi, and A. Mori Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas Int J Gynecol Pathol 18 1 1999 20 28 (Pubitemid 29028841)
163. K. Mittal, and R.I. Demopoulos MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors Hum Pathol 32 9 2001 984 987 (Pubitemid 32911322)
164. G. Sabini, J.C. Chumas, and W.J. Mann Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study Am J Clin Pathol 97 3 1992 381 386
165. O. Reich, S. Regauer, W. Urdl, M. Lahousen, and R. Winter Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas Br J Cancer 82 5 2000 1030 1034 (Pubitemid 30128855)
166. R.L. Balleine, P.J. Earls, and L.R. Webster Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma Int J Gynecol Pathol 23 2 2004 138 144 (Pubitemid 38391773)
167. X.Q. Zhu, Y.F. Shi, X.D. Cheng, C.L. Zhao, and Y.Z. Wu Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma Gynecol Oncol 92 1 2004 71 79